Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BioTime (NYSE Amex: BTX) appoints CFO

BTX appoints Peter Garcia to the position of Chief Financial Officer.


Mr. Garcia, age 50, will lead the accounting, finance, and investor relations functions and will report directly to Michael D West, Ph.D., President and CEO, and will be an officer of the Company. Robert W. Peabody, who was interim CFO, will continue his role as SVP and COO.

Mr. Garcia has been the CFO of 6 biotech and high-tech companies since 1996, and was instrumental in raising over $500M and leading multiple merger and acquisition transactions for these companies. He was most recently with Marina Biotech Inc. managing finance and investor relations efforts, as well as the corporate communications, IT and facilities functions. From 2004 to 2008, Mr. Garcia was CFO of Nanosys, where he led the efforts in raising the largest private nanotechnology company financing in 2005 ($48M). From 1996 to 2004, Mr. Garcia was CFO of 4 Bay Area biotech companies: Nuvelo, Novacept, IntraBiotics Pharmaceuticals and Dendreon. From 1990 to 1996, he was a financial executive with Amgen. Mr. Garcia graduated from Stanford Universityin 1983 with a Bachelor of Arts degree in economics and sociology with honors. In 1985 he earned his MBA from the University of California Los Angeleswith a concentration in Finance and Accounting.